Trial Details
UNKNOWNBasic Information
| Clinical ID | c2038 |
|---|---|
| Identifier | NCT04074421 |
| Trial Title | Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS - Irritable Bowel Syndrome|Gut Microbiota |
| Interventions | DRUG: Rifaximin|DRUG: Probiotic Formula|DRUG: Placebo oral tablet |
Participant Information
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
|---|---|
| City | Zhejiang |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2020-05-10 |
|---|---|
| Primary Completion Date | 2022-06 |
| Completion Date | 2022-12 |